OraQuick At-Home HIV Test: An Editorial Review
How the U.S. oral-fluid HIV self-test works and when clinical testing or urgent assessment is more appropriate.
What is inside the kit
OraQuick uses an oral-fluid sample to look for antibodies to HIV-1 and HIV-2. The U.S. kit instructions specify a reading interval. The FDA describes a result in 20 to 40 minutes. The device only addresses HIV.
Where timing matters most
The FDA describes a window of about three months for this product. A negative result after a recent exposure may be too early. A clinic can explain earlier-detecting tests and when repeat testing is useful. For possible HIV exposure in the past 72 hours, seek urgent PEP assessment without waiting for a self-test.
Plan what happens after the result
A reactive home result needs confirmatory testing through a healthcare service. Follow the kit instructions if the result is invalid. This source-based review compares specimen type, timing, and follow-up using public information.
Join the discussion